AI in drug discovery Artificial intelligence is rapidly transforming the way new drugs and therapeutic targets are discovered in cancer immunology.

The Silent Killer in MASLD? It's Not Diabetes, Says New StudyA new study published in Clinical Gastroenterology and ...

The connected drug delivery devices market size is calculated at USD 9.18 billion in 2025 and is expected to reach around USD ...

In oncology and cardiology, AI’s strength lies in deep learning techniques applied to imaging and genomic data. Convolutional ...

Discover how AI-based eye scans are transforming healthcare by detecting high blood sugar and heart disease through non-invasive retinal imaging, promising earlier diagnosis and improved patient ...

To keep the mind young, dance the tango. Whether it’s dancing the tango or playing the guitar, engaging in a creative pastime ...

MK-3000, a tri-specific antibody, is being tested in the BRUNELLO trial for diabetic macular edema, following positive ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Using biochemical markers such as estimated glomerular filtration rate (eGFR) and proteinuria improved precision, reaching ...

Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...

Their method found 90% of cancer cases, almost as accurate as colonoscopies (which detect 94%) and better than any other ...